Clinical Trial Update: A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SYN-004 aiming to prevent Clostridioides difficile infection in patients with a lower respiratory tract infection; study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection
• Lower Respiratory Tract Infections

Drugs mentioned

• SYN-004

Snippet

Sponsor: Theriva Biologics, Inc. | Conditions: Clostridium Difficile, Clostridium Infections | Phase 2 | Status: COMPLETED | Results posted: 2018-03-12